SPS 7.10 History
History: Cr.
Register, January, 1991, No. 421, eff. 2-1-91; am.
Register, July, 1996, No. 487, eff. 8-1-96.
SPS 7.11
SPS 7.11
Approval of drug testing programs. The department shall approve drug testing programs for use by credential holders who participate in drug and alcohol monitoring programs pursuant to agreements between the department or boards and credential holders, or pursuant to disciplinary orders. To be approved as a drug testing program for the department, programs shall satisfactorily meet all of the following standards in the areas of program administration, collection site administration, laboratory requirements and reporting requirements:
SPS 7.11(1)
(1) Program administration requirements are:
SPS 7.11(1)(a)
(a) The program shall enroll participants by setting up an account, establishing a method of payment and supplying preprinted chain-of-custody forms.
SPS 7.11(1)(b)
(b) The program shall provide the participant with the address and phone number of the nearest collection sites and shall assist in locating a qualified collection site when traveling outside the local area.
SPS 7.11(1)(c)
(c) Random selection of days when participants shall provide specimens shall begin upon enrollment and the program shall notify designated department staff that selection has begun.
SPS 7.11(1)(d)
(d) The program shall maintain a nationwide toll-free access or an internet website that is operational 24 hours per day, 7 days per week to inform participants of when to provide specimens and is able to document the date and time of contacts by credential holders.
SPS 7.11(1)(e)
(e) The program shall maintain and make available to the department and treatment providers through an internet website data that are updated on a daily basis verifying the date and time each participant was notified after random selection to provide a specimen, the date, time and location each specimen was collected, the results of drug screen and whether or not the participant complied as directed.
SPS 7.11(1)(f)
(f) The program shall maintain internal and external quality of test results and other services.
SPS 7.11(1)(g)
(g) The program shall maintain the confidentiality of participants in accordance with s.
146.82, Stats.
SPS 7.11(1)(h)
(h) The program shall inform participants of the total cost for each drug screen including the cost for program administration, collection, transportation, analysis, reporting and confirmation. Total cost shall not include the services of a medical review officer.
SPS 7.11(1)(i)
(i) The program shall immediately report to the department if the program, laboratory or any collection site fails to comply with this section. The department may remove a program from the approved list if the program fails to comply with this section.
SPS 7.11(1)(j)
(j) The program shall make available to the department experts to support a test result for 5 years after the test results are released to the department.
SPS 7.11(1)(k)
(k) The program shall not sell or otherwise transfer or transmit names and other personal identification information of the participants to other persons or entities without permission from the department. The program shall not solicit from participants presently or formerly in the monitoring program or otherwise contact participants except for purposes consistent with administering the program and only with permission from the department.
SPS 7.11(1)(L)
(L) The program and laboratory shall not disclose to the participant or the public the specific drugs tested.
SPS 7.11(2)
(2) Collection site administration requirements are:
SPS 7.11(2)(a)
(a) The program shall locate, train and monitor collection sites for compliance with the U.S. department of transportation collection protocol under
49 CFR 40.
SPS 7.11(2)(b)
(b) The
program shall require delivery of specimens to the laboratory within 24 hours of collection.
SPS 7.11(3)(a)
(a) The program shall utilize a laboratory that is certified by the U.S. department of health and human services, substance abuse and mental health services administration under
49 CFR 40. If the laboratory has had adverse or corrective action, the department shall evaluate the laboratory's compliance on a case by case basis.
SPS 7.11(3)(b)
(b) The program shall utilize a laboratory capable of analyzing specimens for drugs specified by the department.
SPS 7.11(3)(c)
(c) Testing of specimens shall be initiated within 48 hours of pickup by courier.
SPS 7.11(3)(d)
(d) All positive drug screens shall be confirmed utilizing gas chromatography in combination with mass spectrometry, mass spectrometry, or another approved method.
SPS 7.11(3)(e)
(e) The laboratory shall allow department personnel to tour facilities where participant specimens are tested.
SPS 7.11(4)
(4) The requirements for reporting of results are:
SPS 7.11(4)(a)
(a) The program shall provide results of each specimen to designated department personnel within 24 hours of processing.
SPS 7.11(4)(b)
(b) The program shall inform designated department personnel of confirmed positive test results on the same day the test results are confirmed or by the next business day if the results are confirmed after hours, on the weekend or on a state or federal holiday.
SPS 7.11(4)(c)
(c) The program shall fax, e-mail or electronically transmit laboratory copies of drug test results at the request of the department.
SPS 7.11(4)(d)
(d) The program shall provide a medical review officer upon request and at the expense of the participant, to review disputed positive test results.
SPS 7.11(4)(e)
(e) The program shall provide chain-of-custody transfer of disputed specimens to an approved independent laboratory for retesting at the request of the participant or the department.
SPS 7.11 History
History: Cr.
Register, January, 2001, No. 541, eff. 2-1-01;
CR 10-081: am. (1) (d), (e)
Register December 2010 No. 660, eff. 1-1-11.
